didimethylsulfoxide-dichloroplatinum(ii) and Maxillary-Neoplasms

didimethylsulfoxide-dichloroplatinum(ii) has been researched along with Maxillary-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for didimethylsulfoxide-dichloroplatinum(ii) and Maxillary-Neoplasms

ArticleYear
Inner ear impairment following combined CDDP (platinum preparation) and radiation therapy.
    Auris, nasus, larynx, 1990, Volume: 17, Issue:3

    Hearing ability was examined in patients with head and neck cancer treated by combined CDDP and electron beam therapy. In 3 of 7 patients with maxillary cancer, hearing impairment apparently attributable to the therapy was noted on the affected side. In one of these 3 patients, the temporal bone was observed, but the cause of hearing impairment could not be determined. We present patients with cancer of the external ear in whom radiation-caused hearing impairment worsened probably due to combined CDDP and electron beam therapy.

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Ear, Inner; Female; Hearing Disorders; Humans; Male; Maxillary Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Radiotherapy; Temporal Bone

1990